Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 3, 2013, Pages 537-542

  Dbouk, Nader ^a,b   Parekh, Samir ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Antinuclear antibody; Antismooth muscle antibody; Autoimmune hepatitis; Liver transplantation

Indexed keywords

ANTINUCLEAR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SMOOTH MUSCLE ANTIBODY; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC GRAFT REJECTION; DRUG DOSE REDUCTION; ETHNICITY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY;

EID: 84874356636     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07125.x     Document Type: Article

References (24)

1. Vogel A, Heinrich E, Bahr MJ etal. Long term outcome of liver transplantation for autoimmune hepatitis. Clin. Transplant. 2004; 18: 62-9.
2. Krawitt EL. Autoimmune hepatitis. N. Engl. J. Med. 2006; 354: 54-66.
3. Mottershead M, Neuberger J. Transplantation in autoimmune liver diseases. World J. Gastroenterol. 2008; 14: 3388-95.
4. Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS Liver Transplant Registry. Clin. Transpl. 2004; 354: 315-29.
5. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
6. Campsen J, Zimmerman MA, Trotter JF etal. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl. 2008; 14: 1281-6.
7. Neuberger J. Transplantation for autoimmune hepatitis. Semin. Liver Dis. 2002; 22: 379-85.
8. Khalaf H, Mourad W, El-Sheikh Y etal. Liver transplantation for autoimmune hepatitis: a single center experience. Transplant. Proc. 2007; 39: 1166-70.
9. Molmenti EP, Netto GJ, Murray NG etal. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl. 2002; 8: 519-26.
10. Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl. 2006; 12: 1813-24.
11. Duclos-Vallee JC, Sebagh M, Rifai K etal. A 10year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 2003; 52: 893-7.
12. Ayata G, Gordon FD, Lewis WD etal. Liver transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology 2000; 32: 185-92.
13. Kotlyar DS, Campbell MS, Reddy KR. Recurrence of diseases following orthotopic liver transplantation. Am. J. Gastroenterol. 2006; 101: 1370-8.
14. Hubscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors and outcome. Liver Transpl. 2001; 7: 285-91.
15. Schreuder TC, Hubscher SG, Neuberger J. Autoimmune liver disease and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl. Int. 2009; 22: 144-52.
16. Mendes F, Couto CA, Levy C. Recurrent and de novo autoimmune liver diseases. Clin. Liver Dis. 2011; 15: 859-78.
17. Montana-Loza AJ, Carpenter HA, Czaja AJ. Clinical significance of HLA DRB1*03-DRB1*04 in type 1 autoimmune hepatitis. Liver Int. 2006; 26: 1201-8.
18. Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 2008; 24: 298-305.
19. Hayashi M, Keefe EB, Krams SM etal. Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl. Surg. 1998; 4: 208-14.
20. Narumi S, Hakamada K, Sasaki M etal. Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant. Proc. 1999; 31: 1955-6.
21. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68: 253-6.
22. Czaja AJ. Recurrent autoimmune hepatitis after liver transplantation: a disease continuum or a fresh start? Liver Transpl. 2009; 15: 1169-71.
23. Padilla M, Mayorga R, Carrasco F etal. Liver transplantation for autoimmune hepatitis in Peru: outcomes and recurrence. Ann. Hepatol. 2012; 11: 222-7.
24. Montano-Loza AJ, Mason AL, Ma M, Bastiampillai RJ, Bain VG, Tandon P. Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl. 2009; 15: 1254-61.